Compare FOLD & BNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOLD | BNL |
|---|---|---|
| Founded | 2002 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.3B |
| IPO Year | 2007 | 2020 |
| Metric | FOLD | BNL |
|---|---|---|
| Price | $14.19 | $17.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $29.79 | $19.86 |
| AVG Volume (30 Days) | ★ 14.8M | 2.3M |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 6.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.47 |
| Revenue | ★ $598,704,000.00 | $447,973,000.00 |
| Revenue This Year | $21.49 | $5.68 |
| Revenue Next Year | $18.25 | $7.27 |
| P/E Ratio | ★ N/A | $37.34 |
| Revenue Growth | ★ 21.28 | 5.49 |
| 52 Week Low | $5.51 | $13.96 |
| 52 Week High | $14.36 | $18.87 |
| Indicator | FOLD | BNL |
|---|---|---|
| Relative Strength Index (RSI) | 91.10 | 44.27 |
| Support Level | $10.64 | $17.34 |
| Resistance Level | $11.14 | $17.91 |
| Average True Range (ATR) | 0.36 | 0.29 |
| MACD | 0.28 | 0.02 |
| Stochastic Oscillator | 96.46 | 45.39 |
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.